Pathozone, 250 mg/10 ml, zawiesina dowymieniowa dla bydła
Pathozone, 250 mg/10 ml, zawiesina dowymieniowa dla bydła
Authorised
- Cefoperazone sodium
Product identification
Medicine name:
Pathozone, 250 mg/10 ml, zawiesina dowymieniowa dla bydła
Active substance:
- Cefoperazone sodium
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cefoperazone sodium
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal48hour
-
Milk84hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51DD12
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Available in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Fixed combination application (Article 13b of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Polska Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 0665
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022